Hepatic Steatosis
Conditions
Brief summary
Our study aims to evaluate whether the Emergency Department (PS) can support the health system to improve the prevention and management of chronic inflammatory diseases and ensure actions aimed at screening, raising awareness and informing the population. Specifically, the determination of the prevalence of a widely diffused pathology such as fatty liver disease aims to be the precursor of future pilot studies aimed at evaluating the advantages and critical issues of the PS as a prevention tool.
Interventions
At the time of access to the emergency room, a cohort of male and female patients aged 18 or over will be consecutively recruited with green or white color coded triage. patients who agree to participate in the study will undergo liver ultrasound. Patients who test negative on ultrasound evaluation for liver hyperechogenicity will be part of the control group.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients over 18 * Patients admitted to Emergency department in white or green code
Exclusion criteria
* Patients under 18 * Patients admitted to Emergency department in yellow or red code
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluation of the number of steatotic patients who access the emergency room - Emergency room as a tool for early diagnosis of hepatic steatosis | 12 months | Evaluation of the effectiveness of the Emergency Department as a screening tool for the emergence of the submerged by measuring the prevalence, on the national territory, of hepatic steatosis in patients who access the emergency room. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Develop new prognostic algorithms for assessing the risk of major and minor clinical events in patients with fatty liver. | 36 months | Improve the approval rating of the service offered by the PS to the patient who has been assigned a white or green color code for triage.To develop new prognostic algorithms for assessing the risk of major and minor clinical events in patients with fatty liver. |
Countries
Italy